VPVenkatesh Dinnekere Puttegowda

Venkatesh Dinnekere Puttegowda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Venkatesh Dinnekere Puttegowda has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Resveratrol-loaded Superparamagnetic Iron Oxide Nanoparticles: A Theranostic Approach for Breast Cancer

    by D.B. Pranitha, J. Joysa Ruby, D.P. Venkatesh

    Introduction: Breast cancer is still one of the leading causes of cancer morbidity and mortality in women worldwide, despite advances in surgery, chemotherapy, hormone therapy, and targeted therapies. Conventional therapeutic methods may encounter challenges such as systemic toxicity, development of multidrug resistance, poor tumor targeting, and the possibility of relapse of the disease. Methods: This review explores the mechanism of breast cancer development, the possible anticancer properties and pharmacokinetics of resveratrol, and the possibilities for preparing resveratrol-loaded superparamagnetic iron oxide nanoparticles (SPIONs). Results: In breast cancer models, resveratrol, a naturally occurring polyphenolic compound, has demonstrated strong anticancer activity through its pro-apoptotic, antiproliferative, antiangiogenic, and antimetastatic properties. However, poor aqueous solubility, low bioavailability, rapid metabolism, and restricted tumor accumulation impede its practical translation. Nanotechnology-based drug delivery systems, particularly SPIONs, offer a feasible solution to overcome these limitations. The ability to functionalize their surface, biocompatibility, and responsiveness to magnetic fields make SPIONs suitable for controlled release and targeted drug delivery. Moreover, their intrinsic magnetic properties allow their use as contrast agents in magnetic resonance imaging, facilitating simultaneous diagnosis and therapy, a concept known as theranostics. Discussion: Moreover, a critical analysis of preclinical evidence, targeted mechanisms, therapeutic advantages over free resveratrol, clinical translation barriers, and future perspectives is also performed. Conclusion: The combination of resveratrol and SPION-based nanoplatforms is a promising approach for targeted and image-guided therapy of breast cancer, and it deserves further optimization and clinical trials.

  • Enhancing Rifampicin Solubility: Development and Evaluation of Biodegradable Chitosan Nanosuspensions

    by Priyanka Sahu, Roopa Karki, Venkatesh Dp, Sonam M Gandhi, Bhupendra G. Prajapati, Samresh Pal Roy, Aastha N. Chaudhari, Devesh U Kapoor

    Tuberculosis is the leading cause of mortality from infectious diseases worldwide, with rifampicin as a first-line drug. However, its poor solubility and inconsistent bioavailability limit therapeutic outcomes and contribute to drug resistance. This study aimed to enhance rifampicin solubility and delivery using chitosan-based nanosuspensions. Rifampicin-loaded nanosuspensions were prepared by the ionic gelation method employing chitosan as a biodegradable polymer and Pluronic F68, Tween 80 and Span 60 as stabilizers. The formulations were evaluated for drug entrapment efficiency, particle size, Polydispersity Index (PDI), zeta potential, morphology (SEM), in-vitro drug release, kinetic modeling and stability. Entrapment efficiency ranged from 75.7% to 89.3%, with Pluronic F68 formulations showing the highest values. The optimized batch (F24) demonstrated a mean particle size of 120.08 nm, PDI of 0.110 and zeta potential of [Formula: see text]48.49 mV, indicating good stability. SEM confirmed spherical, nonagglomerated particles. The optimized nanosuspension achieved a sustained drug release of 87.17% over 12 h and followed zero-order and Korsmeyer–Peppas kinetics. Stability studies revealed consistent performance under refrigerated storage for 60 days. Chitosan-based nanosuspensions significantly improved rifampicin solubility, stability and release profile. The optimized formulation offers a promising approach to overcome bioavailability limitations of rifampicin and may enhance therapeutic efficacy in tuberculosis management. This strategy can potentially be extended to other poorly soluble drugs.


  • Open Access

    In-situ gel drug delivery system as a viable approach to periodontal therapy: A comprehensive review

    by Supreeth Sirangala Vivek, Venkatesh Dinnekere Puttegowda, Joysa Ruby Joseph Rajarathinam, Gunashekar Dhanapal, Naveen Kumar Karimaranahalli Banappa, Chaithanya Kadalu Mahendra, Pooja Rangadham

    This narrative review summarizes recent advances in in situ gel drug delivery systems for periodontal therapy, focusing on formulation strategies, the pharmaceutical agents involved, and their clinical applications. A comprehensive search was conducted on PubMed, Scopus, and Google Scholar for English-language articles published from 2000 to 2024 using relevant keywords. Articles were selected based on their clinical significance, scientific rigor, and relevance to periodontal treatment. In situ gels use physiological stimuli such as pH, temperature, or ions for sol-to-gel transition, enabling sustained and localized drug release into periodontal pockets. These systems aim to improve therapeutic efficacy and reduce systemic side effects. However, limitations like inconsistent gelation, low mechanical strength, and limited long-term clinical data hinder widespread clinical adoption. Future research should focus on formulation optimization and rigorous clinical trials to facilitate the integration of in-situ gels into routine periodontal care.


  • Open Access

    Extraction and Formulation of Lip Tint from Natural Dye Extracted from Celosia Cristata Linn Flower

    by Joysa Ruby J., Selvakumar K, Venkatesh Dp, Ajay Pankajbhai Lunagariya, Chandrika P, Shreyas S Kashyap, Tarun R, Kavitha Choudhary, Tanveer

    The escalating utilisation of synthetic dyes across diverse industries, including textiles, cosmeceuticals, food, and pharmaceuticals, is projected to witness a notable 6.5 % surge by 2027, notwithstanding the well-documented drawbacks associated with their usage. Synthetic dyes have been linked to adverse effects such as skin irritation, necrosis, genotoxicity, and hyperactivity in children. Acknowledging the imperative need to transition towards safer alternatives, this study investigates the extraction and formulation of a lip tint employing a dye derived from Celosia cristata Linn as a natural substitute for synthetic dyes. The aqueous extraction of Celosia cristata Linn flower unveiled the presence of various phytochemical constituents, including flavonoids, tannins, phenols, steroids, terpenoids, quinones, cellulose, starch, and saponins. Particularly noteworthy is the betalain constituent in the flower extract, which imparts the dye with nutraceutical, antioxidant, and anti-inflammatory properties. The formulated lip tint underwent a comprehensive evaluation encompassing dye stability, spreadability, melting point, skin irritation, surface anomalies, homogeneity, perfume stability, pH, short-term stability, and colorant yield. The study concludes that the lip tint formulated from Celosia cristata Linn dye represents a viable and safe alternative for various cosmeceutical applications, providing a natural solution to the adverse effects associated with synthetic dyes.

  • Formulation and Evaluation of Nanosponges Loaded Bifonazole for Fungal Infection

    by Amaravathi Murali Krishna, Venkatesh Dinnekere Putte Gowda, Roopa Karki

    Background: Nanosponge is a novel approach to topical drug delivery, especially for fungal infections. Nanosponges are a unique class of nanoparticles with three-dimensional nanostructure and nanometers wide cavities, which can encapsulate both hydrophilic and lipophilic substances providing increased efficacy and safety. Objective: To formulate and evaluate Bifonazole loaded nanosponges in hydrogels for the treatment of fungal diseases. Methods: Bifonazole-loaded nanosponges were formulated using the emulsion solvent diffusion technique. Interaction of drug-ethyl cellulose polymer along with other excipients’ was done by using FTIR as well as DSC. The nanosponges formulations were evaluated with different parameters. Results: Particle size and Zeta potential of Bifonazole loaded nanosponges for formulations were between the range of 183.7 to 560.2 nm and –17.77 to –21.9 mV, respectively. The surface morphology of nanosponges by SEM disclosed that it was spherical and porous in nature. Drug entrapment efficiency was found to be 45.44 to 79.71%. The drug release study was done by using a phosphate buffer with a pH of 6.8. Further in vitro release data was fitted into kinetic models. The optimized formulation M6 was incorporated with hydrogels; to further evaluated using parameters such as in vitro drug release studies, viscosity, pH and skin irritation studies using rat model. Stability studies of hydrogel formulation MH2 revealed no changes in in-vitro drug release, pH and drug content study at the completion of 6 months. Conclusion: Thus, the findings indicated that the prepared Bifonazole loaded nanosponges into hydrogel were stable. Hence, it could be a suitable dosage form for the cure of fungal infections in the skin.


  • Open Access

    Formulation and Pharmacokinetic Evaluation of Microcapsules Containing Pravastatin Sodium Using Rats

    by Venkatesh Dinnekere Puttegowda, Roopa Karki, Divakar Goli, Sajal Kumar Jha, Manjunatha Panduranga Mudagal

    Pravastatin Sodium has a cholesterol lowering agent. It has shorter half-life and undergoes first-pass metabolism. Frequent dose is required in case of conventional dosage form. The purpose of the study is to formulate and evaluate microcapsules containing Pravastatin Sodium by complex with cholestyramine resins coated with Eudragit RLPO and Eudragit RSPO polymers for achieving control release. Complexation of drug on resin was carried out by batch method. Microencapsulation was carried out by nonaqueous solvent evaporation method. Pharmacokinetic studies were done by using rats. The intermediate stability studies were carried out on the most satisfactory formulations. FTIR, X-ray diffraction, and DSC spectra of drug, drug-resinates, and polymers revealed no chemical interaction. The % DEE and % yield were observed for formulations of f1 to f7 that were varied from 97.1 ± 0.8 to 98.9 ± 0.5% and 95.0 ± 3.25 to 98.8 ± 7.1%, respectively. Most satisfactory formulation, f6, showed drug release up to 72.6%. No changes in % DEE and % CDR were observed after stability studies. Microcapsules of f6 formulation achieved best performance regardingin vitrodrug release and from pharmacokinetic evaluation mean residence time was found to be 6.3 h, thus indicated, Pravastatin Sodium microcapsules were released and absorbed slowly over a prolonged period of time.